Dolecek Gayle R 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Jan 26, 2010
Insider Transaction Report
Form 4
Dolecek Gayle R
DirectorVP of Research & Development
Transactions
- Award
Employee Stock Option (Right to buy)
2010-01-15+35,000→ 35,000 totalExercise: $3.85Exp: 2020-01-15→ Class A common stock (35,000 underlying)
Footnotes (1)
- [F1]The option is vested as to 8,750 shares immediately, with the remaining shares vesting in three equal installments of 8,750 each on the first, second and third anniversaries of the grant date.